157 related articles for article (PubMed ID: 1709642)
1. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
Hassan HT; Veit A; Maurer HR
J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642
[TBL] [Abstract][Full Text] [Related]
2. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.
Hassan HT; Zyada LE; Ragab MH; Rees JK
Eur J Clin Pharmacol; 1991; 41(6):531-6. PubMed ID: 1815964
[TBL] [Abstract][Full Text] [Related]
3. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro.
Kong XB; Fanucchi MP; Chou TC
Leuk Res; 1988; 12(10):853-9. PubMed ID: 3199844
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents.
Chen A; Licht JD; Wu Y; Hellinger N; Scher W; Waxman S
Blood; 1994 Oct; 84(7):2122-9. PubMed ID: 7919325
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha A interferon.
Gallagher RE; Lurie KJ; Leavitt RD; Wiernik PH
Leuk Res; 1987; 11(7):609-19. PubMed ID: 3475513
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human interleukin-6 enhances the antiproliferation and differentiation inducing effects of retinoic acid in HL-60 human myeloid leukaemic cells.
Hassan HT
Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):847-51. PubMed ID: 1797449
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.
Miller WH; Maerz WJ; Kurie J; Moy D; Baselga J; Lucas DA; Grippo JF; Masui H; Dmitrovsky E
Differentiation; 1994 Jan; 55(2):145-52. PubMed ID: 8143931
[TBL] [Abstract][Full Text] [Related]
10. Triple combination of retinoic acid + 6-thioguanine + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
Tawhid H; Rees J
Leuk Res; 1990; 14(2):109-17. PubMed ID: 2314112
[TBL] [Abstract][Full Text] [Related]
11. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
12. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells.
Tobler A; Munker R; Heitjan D; Koeffler HP
Blood; 1987 Dec; 70(6):1940-6. PubMed ID: 2823943
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
15. Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.
Rowinsky EK; Donehower RC; Spivak JL; Burke PJ; Griffin CA; Jones RJ
J Natl Cancer Inst; 1990 Dec; 82(24):1926-31. PubMed ID: 2250314
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
17. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA.
Liu J; Bi G; Wen P; Yang W; Ren X; Tang T; Xie C; Dong W; Jiang G
Cell Mol Immunol; 2007 Feb; 4(1):59-63. PubMed ID: 17349212
[TBL] [Abstract][Full Text] [Related]
19. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
20. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
Khan MZ; Freshney RI; McNicol AM; Murray AM
Ann Oncol; 1993 Jun; 4(6):499-507. PubMed ID: 8394737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
